Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May;80(5):1208-1225.
doi: 10.1111/all.16519. Epub 2025 Mar 5.

Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps

Affiliations
Review

Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps

Mu Xian et al. Allergy. 2025 May.

Abstract

Emerging biologics that selectively target key cytokines present a promising therapeutic alternative for patients suffering from severe, uncontrollable chronic rhinosinusitis with nasal polyps (CRSwNP). Despite the limited availability of registered biologics for CRSwNP treatment in China, the country is experiencing rapid development in this field. It is imperative to standardize the application of biologic agents in CRSwNP management in preparation for their future integration into the CRSwNP care pathway. The Rhinology Group, Chinese Society of Otorhinolaryngology-Head and Neck Surgery; the Rhinology Group, Chinese Medical Doctor Association of Otorhinolaryngology-Head and Neck Surgery; and the Nasal and Ocular Allergy Group, Chinese Society of Allergy have convened an expert panel consisting of principal investigators experienced in clinical trials of biologic treatment for CRSwNP. This expert panel was assembled to discuss the application of biologic agents in patients with CRSwNP in China. Additionally, the latest findings on the pathogenesis of CRSwNP, mechanisms of biologic agents, and efficacy and safety of biologic treatment in patients with CRSwNP were reviewed, with a special emphasis on research evidence from China. The expert panel reached a consensus on several critical issues, including criteria for the prescription, treatment course, and efficacy evaluation from a Chinese perspective. This position paper aims to guide Chinese physicians in the use of biologic agents for patients with CRSwNP. As our experience with biologic treatment continues to grow, this position paper will be further updated.

Keywords: China; biologics; chronic rhinosinusitis with nasal polyps; monoclonal antibody; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Pathogenesis of chronic rhinosinusitis with nasal polyps and biologics targeting key molecules mediating type 2 inflammation. EOS, eosinophil; DC, dendritic cell; B, B cell; Th, T helper cell; IL, interleukin; IgE, immunoglobulin E; IL‐4Rα, IL‐4 receptor alpha; TSLP, thymic stromal lymphopoietin. Figure were created with BioRender.com (agreement number: ZP27HEOIU0).
FIGURE 2
FIGURE 2
Indication for biological treatment in CRSwNP. CRSwNP, chronic rhinosinusitis with nasal polyp; NPS, nasal polyp score; NCS, nasal congestion score; HPF, high‐power field.
FIGURE 3
FIGURE 3
Flow chart of biologic treatment monitoring. NPS, nasal polyp score. †Decrease in NPS compared with baseline. ‡ Physicians can adjust the course based on individual patient's situation and preferences beyond 12 months.

References

    1. Fokkens W. J., Lund V. J., Hopkins C., et al., “European Position Paper on Rhinosinusitis and Nasal Polyps 2020,” Rhinology 58, no. Suppl S29 (2020): 1–464. - PubMed
    1. Shi J. B., Fu Q. L., Zhang H., et al., “Epidemiology of Chronic Rhinosinusitis: Results From a Cross‐Sectional Survey in Seven Chinese Cities,” Allergy 70, no. 5 (2015): 533–539. - PMC - PubMed
    1. Bachert C., Bhattacharyya N., Desrosiers M., and Khan A. H., “Burden of Disease in Chronic Rhinosinusitis With Nasal Polyps,” Journal of Asthma and Allergy 14 (2021): 127–134. - PMC - PubMed
    1. Stevens W. W., Schleimer R. P., and Kern R. C., “Chronic Rhinosinusitis With Nasal Polyps,” Journal of Allergy and Clinical Immunology: In Practice 4, no. 4 (2016): 565–572. - PMC - PubMed
    1. Bhattacharyya N., Villeneuve S., Joish V. N., et al., “Cost Burden and Resource Utilization in Patients With Chronic Rhinosinusitis and Nasal Polyps,” Laryngoscope 129, no. 9 (2019): 1969–1975. - PMC - PubMed

Publication types

Substances